WAIKOLOA, Hawaii — Patient history, growth rate and bleeding are important factors to consider when evaluating eyelid lesions and deciding whether or not to biopsy, according to a speaker.
“There are situations where we need to have heightened awareness. These skin cancers occur, and they can evolve,” Jeremiah Tao, MD, FACS, said during a presentation at Hawaiian Eye 2026.
“On examination, there are three key findings I think we should all be considering: Ulceration, irregularity and eyelid margin destruction. These are three features that should prompt you to put these patients into the